> It is much more important to know which sort of a patient has a disease than to know what sort of disease a patient has.
>
> *William Osler*

Medical screening of foreign-born individuals, including immigrants, refugees and children adopted abroad is undertaken for two major purposes. New arrivals may benefit from recommended or indicated screening for medical conditions that have implications in terms of personal and community health. Additionally, foreign nationals seeking residence through organized immigration and refugee programs are required to undergo screening according to legislative, regulatory, or administrative directive. Similar epidemiologic principles govern the science and the application of both screening processes. However, the rationale underlying these two screening approaches differs in terms of historical basis, operational characteristics, and ultimate goals. Mandatory medical screening for immigration purposes is used for regulatory reasons, such as the determination of inadmissibility on medical grounds for immigration applicants. It often takes place or begins abroad as a component of the formal immigration process. Screening for medical conditions of personal health significance is intended to improve health parameters or outcomes for the migrant following arrival or re-settlement.

The effective and appropriate use in either situation requires understanding of the science and the application of screening and the tools used in the process. This includes an appreciation of the profile of risk and benefit for the individual or community and the outcome performance of the testing instruments used. Important test performance characteristics relate to the sensitivity, specificity, predictive values, and pre/post-test likelihood of the condition of interest being present. The subsequent value or utility of the test results, particularly as they relate to the provision of effective interventions, further assist in the definition of a good or bad screening test.

Screening in migrant populations can be subject to influences not encountered in mainstream or host populations. The use of screening tests can be affected by linguistic and cultural factors and, for many migrants, some screening programs may be subject to limited availability, accessibility and affordability. These factors may affect the application, interpretation and the use of screening results, including patient compliance with recommendations. Together, these influences determine the acceptability and utility of any screening program in migrant populations.

Medical screening used in the context of clinical or mandatory reasons also needs to be distinguished from other forms of medical testing used for diagnosis or prognosis. In those situations, the individual is usually being evaluated because of an existing presenting complaint, family history, physical finding, or a positive screening test that requires more specific testing to better define a clinical outcome. Diagnostic or prognostic testing usually leads to other interventions, such as medical or surgical therapy, counseling or observation.

Reflecting the duality of screening related to migrants, this chapter on screening is presented in two parts. The first part will address the function and purposes of the mandatory immigration medical screening program and relevance to various migrant classes applying for admission or changing their immigration status in the USA. The second part will discuss the clinical indications for the additional medical screening of new arrivals in the USA for reasons that may not be considered during mandatory immigration medical screening. These indications will apply to migrants who have no clinical indicators of illness or disease but for whom there is personal health benefit from testing based on epidemiologic, demographic, or biometric characteristics.

MANDATORY IMMIGRATION SCREENING IN THE USA -- MEDICAL COMPONENT {#s0010}
===============================================================

The routine examination of travelers and migrants is one of the oldest recorded activities directed at civic administration and protecting the health of the public. Medieval cities prevented or controlled the admission of new arrivals with certain illnesses, such as leprosy. These types of interventions originated before it was known that microorganisms are the agents of transmissible diseases; they predated the development of epidemiology and regulated public health measures for disease control. The later development of quarantine practices in the mid-14th century was associated with the routine inspection of new arrivals, commercial goods, and conveyances in an attempt to prevent the introduction of epidemic infectious diseases. Those deemed to be at risk following inspection were contained, excluded or expelled.

Shortly after achieving nationhood, early legislative tools were introduced creating the US Public Health Service, whose initial role was to provide medical care to seafarers and to control the importation of serious diseases epidemic at the time, such as cholera and plague. A linkage to immigration later followed with the screening of immigrants to exclude those with unwanted medical conditions such as certain loathsome diseases, individuals of suspected low moral behavior, and people with mental deficiencies who were likely to become wards of the state. In the USA, this process began in the late 1800s when the control of immigration was legally recognized as a congressional responsibility. Subsequently, the US Immigration Act of 1882 made specific reference to controlling the admission of immigrants on medical grounds. The routine medical inspection of immigrants was legislatively mandated in the USA in 1891.

Public health programs and policies designed to manage the major medical challenges of the day became linked to the routine medical inspection of immigrants on arrival. By the 1920s, the immigration medical inspection was extended to the European points of origin for the majority of migrants, creating a system of pre-departure immigration medical screening that continues to this day.

The US Citizenship and Immigration Service (USCIS), a Bureau of the Department of Homeland Security, is responsible for the administration of the immigration process. USCIS receives technical advice on the medical and health aspects of immigration from the Division for Global Migration and Quarantine, Centers for Disease Control and Prevention, Health and Human Services. Details of this process and supporting information can be found at the United States Citizenship and Immigration Service and the CDC. They contain material that is relevant to the physician who encounters immigrants and refugees in their practice, and explain the details regarding the medical basis of inadmissibility and the role of waivers for those who may otherwise be deemed to be medically inadmissible.

The Department of Health and Human Services is responsible for preventing the introduction, transmission, and spread of communicable diseases in the USA. Under its authority, the Division of Global Migration and Quarantine establishes standards for medical examination of persons destined for the USA. The legal foundation for these activities is found in Titles 8 and 42 of the US Code and relevant supporting regulations. '*Medical grounds of inadmissibility*' can occur when an applicant has a health condition which is a public health concern to the USA. Grounds of medical inadmissibility are divided into four categories:•A communicable disease of public health significance•The lack of required vaccinations (for immigrant visa applicants only)•A physical or mental disorder with harmful behavior•The presence of drug abuse or drug addiction.

Each of these categories of medical inadmissibility grounds is further classified into Class A or Class B conditions by the examining panel physicians performing the immigration medical assessment. Class A is any condition that poses a significant risk to public health, public order, or personal life, and renders the applicant inadmissible on medical grounds, unless a waiver is obtained. Class B conditions are defined as a past health history or current physical examination that may require medical follow-up for the well-being of the individual. Conditions with no current or future personal health consequences are not classified or noted on the application. Class B conditions do not render the individual medically inadmissible.

A 'communicable disease of public health significance' is defined in regulation and includes the following nine infectious medical conditions: severe acute respiratory syndrome (SARS), tuberculosis (TB), leprosy (Hansen\'s disease), human immunodeficiency virus (HIV/AIDS), infectious syphilis, chancroid, gonorrhea, granuloma inguinale, and lymphogranuloma venereum.

For example, an applicant with active infectious tuberculosis (open pulmonary tuberculosis with a positive smear for acid-fast bacilli) has a Class A condition which is medically inadmissible to the USA, but active, non-infectious and inactive tuberculosis (both smear negative) are Class B conditions and the applicant can be admitted to the USA. Other Class A conditions include: human immunodeficiency virus (HIV) positive serology, untreated lepromatous leprosy (Hansen\'s disease), and untreated sexually transmitted diseases (syphilis, gonorrhea, chancroid, granuloma inguinale, and lymphogranuloma venereum).

Class B conditions are not grounds for exclusion but must be reported. Class B conditions include inactive or treated tuberculosis, treated sexually transmitted diseases, tuberculoid leprosy, and treated lepromatous leprosy.

Panel physicians examine all individuals who require medical clearance to enter the USA (e.g., all refugees, all applying or immigrant visas, and some individuals who apply for non-immigrant (visitor) visas). Panel physicians are selected by the US State Department. The panel physicians receive technical instruction and guidance from the Division of Global Migration and Quarantine, CDC. Medical history and physical examination are required for all individuals (see summary in [Table 18.1](#t0010){ref-type="table"} ). In addition, applicants who are ≥15 years undergo routine chest radiography and serologic testing for HIV and syphilis. Depending on the clinical history and radiological findings, supplementary screening requirements for tuberculosis may include smears of respiratory secretions for AFB and tuberculin skin testing. Class A tuberculosis cases (smear positive infectious) generally must be treated until their sputum smears are negative before they are allowed to transit for immigration.TABLE 18.1Mandatory immigration screening -- medical componentCriteriaConditionsScreening toolExceptionsCommunicable diseases of public health significanceTuberculosisChest X-ray; ≥15 years of ageTST (tuberculin skin testing) for children aged ≥2 years for applicants to USALeprosy, chancroid, gonorrhea, granuloma inguinale, and lymphogranuloma venereumHistory and physical examination. Laboratory testing only if clinically indicatedApplicants who are asymptomatic. Contacts of documented infected applicantsHuman immunodeficiency virus (HIV/AIDS), infectious syphilisSerological tests; ≥15 years of ageApplicants who are contacts of documented infected applicants (e.g., children, spouse)VaccinationsMumps, measles, rubella, polio, tetanus, diphtheria, pertussis, pneumococcal infections, influenza type B, varicella and hepatitis BReview of vaccination recordsPhysical or mental disorder with harmful behaviorHistory of ever having caused serious injury to others; major property damage; or history of trouble with the law because of a medical condition, mental condition, or influence of alcohol or drugs, or having ever attempted suicideHistory and physical examination\
Review of recordsPresence of drug abuse or drug addictionDrug use: amphetamines, cannabis, cocaine, hallucinogenics, inhalants, opioids, phencyclidines, sedative-hypnotics, or anxiolyticsOther substance-related disorders including: alcohol addiction and abuse, associated with other harmful behaviors such as driving under the influence of alcohol, domestic violence, or other alcohol-related criminal behavior

Since 1996, individuals applying for immigrant visas to entry into the USA have had to demonstrate proof of vaccination for several vaccine-preventable diseases, as recommended by the Advisory Committee for Immunization Practices. Currently those diseases are: mumps, measles, rubella, polio, tetanus, diphtheria, pertussis, pneumococcal infections, influenza type B, varicella and hepatitis B. Immunizations recommended and required for US immigration purposes are summarized in the CDC\'s 'Requirements for Routine Vaccination of Immigrants Examined Overseas Who are not Fully Vaccinated or have no Documentation', available from: <http://www.cdc.gov/ncidod/dq/pdf/Tbl1.pdf>.

Pre-admission vaccination requirements do not apply for refugees or non-immigrant visa applicants. However, those individuals are required to meet the vaccination standards when they adjust their status in the USA after admission. As a procedural consequence, the immunization status of refugees is recorded during immigration process.

Recently, vaccine-preventable diseases associated with international adoptees, such as measles, have highlighted the risk of importation of these conditions that are well-controlled or virtually eliminated in the local US population. The cost-effectiveness of preventative medical interventions in the overseas environment, before transit to the USA and before any potential personal health risk or community exposure occurs within the health services environment and public health domain of the USA, is receiving greater attention as a potential part of the immigration medical process for health promotion and disease prevention. Currently, some refugee populations being resettled in the USA who are determined to be at increased risk for specific infections receive population-based treatment for malaria and intestinal parasites in addition to the routine immigration medical screening.

In terms of harmful behavior, immigration medical screening is intended to identify those with neurologic or behavioral conditions associated with the risk of 'ever causing serious injury to others, major property damage or having trouble with the law because of a medical condition, mental condition, or influence of alcohol or drugs' or 'ever taken actions to end your \[the applicant\'s\] life'. High-risk conditions in this group may be determined to be Class A (inadmissible) or Class B (admissible) conditions by panel physicians depending upon clinical findings, history and situation.

Addiction (dependence) and abuse of any of the controlled substances in the USA in the drug class of amphetamines, cannabis, cocaine, hallucinogenics, inhalants, opioids, phencyclidines, sedative-hypnotics, or anxiolytics are also Class A conditions. Other substance-related disorders, including alcohol addiction and abuse associated with other harmful behaviors, such as driving under the influence of alcohol, domestic violence, or other alcohol-related criminal behavior, may be Class A conditions as well.

Summary {#s0020}
-------

Mandatory medical screening to determine medical inadmissibility for immigration purposes is an important administrative process for applicants for permanent residency in the USA and may also be applied to certain temporary resident applicants. The purpose of this screening is to ensure good public health and the avoidance of specific imported harmful outcomes affecting the community or individual.

Although the immigration medical examination does screen for some important medical conditions, it has clinical limitations. It is not designed to be a tool for identifying personal health risks and it is procedurally limited to specific disorders and conditions of regulated public health concern. As a consequence, pre-existing medical conditions that do not fall under the immigration medical screening profile and other medical conditions of personal health significance may not be detected or reported during mandatory immigration screening. Those conditions, while not relevant for immigration purposes, can be significant for new arrivals and their identification and clinical management in the USA is important in some migrant populations.

Documents providing further operational descriptions on the immigration medical screening process for both applicants abroad and those applying within the USA, including details on applicants seeking a change in immigration status, the use of Civil Surgeons, and reporting requirements are available at: <http://www.cdc.gov/ncidod/dq/health.htm>

The incubating or quiescent medical conditions of importance to new arrivals in the USA can be considered in two groups: those conditions for which existing screening programs are available for the local population but represent conditions that also occur in migrants, and those conditions not endemic in the USA affecting particular demographics or biometric groups of migrants for which no routine screening programs exist in the USA. These conditions are considered in Part 2.

MEDICAL SCREENING OF NEW ARRIVALS IN THE USA {#s0030}
============================================

The US Census Bureau estimates that there are just over 300 million citizens in the USA, with more than 10% foreign-born residents, which is the highest percentage for almost a century. From July 1, 2004 to July 1, 2005, there was a net legal international migration to the USA of 1 049 526 people, representing over 38% of the US population growth in a single year. In addition to an absolute increase in immigration, there has been a shift in source countries, with immigrants from Latin American nations other than Mexico, Africa, Asia, and Oceania increasingly contributing to the immigrant pool. This represents a significant change in mobile population demographics, and in some cases contributes significantly to a changing prevalence of diseases seen in the USA.

The growing number and increasing diversity of foreign-born residents of the USA is important in numerous areas of clinical practice. Due to the health environments at their place of origin and conditions of relative disparity, migrants may have greater risk of adverse health determination resulting in disease exposure and acquisition. In some communities, migrants represent rapidly increasing components of the population and their specific health concerns may be different from those of the receiving community. International adoptions, for example, are now a major component of the adoption process in the USA. Of the \>1.6 million adopted children in the USA since 1986, 13% were foreign-born, representing over 200 000 individuals. Approximately one-third of these children have arrived from China or Russia in the last 7 years. Appropriately targeted and applied screening can assist in meeting the differential health challenges of these diverse foreign-born populations.

Increasing cultural and linguistic diversity poses challenges to health systems and for physician and institutional healthcare service delivery. The Office for Minority Health is mandated to 'improve and protect the health of racial and ethnic minority populations. This is to be achieved through the development of health policies and programs that will eliminate health disparities, with a focus on reducing cultural and linguistic barriers to appropriate services in healthcare institutions and to enhance ethnic minority population accessibility to healthcare services. Health screening of immigrants and refugees can be done as part of primary care assessment in which routine immunizations should be documented and brought up-to-date if necessary; maternal--child health issues can be addressed; and specific health assessments for other defined populations (e.g., children, adolescents, women, men the elderly) can be performed.

In addition to language, some migrant groups experience difficulty accessing and utilizing healthcare services for other reasons. Cultural issues, including fear of interacting with official bureaucracies and concerns about affordability, may limit migrants\' use of health prevention and promotional services. Services designed for the general populations often include health counseling and screening programs that may be unfamiliar or underused by migrant populations. Migrants may need special attention in terms of screening for:•Risk behaviors such as smoking, alcohol and other substance abuse•Health implications of diet and exercise•Risks of sexual health practices•Early recognition of mental and psychosocial health•Impact of environmental risks presented by toxic substances including lead in drinking vessels or paint•Occupational exposures related to safe labor practices.

In addition, there are many targeted health promotion activities for specific groups; such as maternal--child care, which may not have been commonly available for many migrants in their home country. Programs, such as prenatal blood pressure monitoring, screening for gestational diabetes, and thyroid function, may be unfamiliar to many migrants. Antenatal screening for infections such as rubella, syphilis, hepatitis B, and HIV can be important in migrant populations who originate from regions of the world where these diseases are more prevalent than they are in the USA, and screening practices are not uniformly available or are unfamiliar to women.

*There are other important targeted screening programs of relevance to migrants*. Migrant children and infants born to newly-arrived migrant parents may require special attention in terms of screening. They may not have had access to genetic screening for inborn errors of metabolism, or physical conditions such as congenital hip dysplasia and cataracts. Additionally, there are several diseases that may be more prevalent at the migrants\' place of origin, such as malaria, thalassemia and micronutrient deficiencies, for which screening may be indicated.

Finally, it is important to note that many migrants may be unfamiliar with the basis and rationale underlying health-screening programs. Common examples include screening programs for malignant disease such as uterine cervical dysplasia (Pap smear), skin, bowel, and breast or prostate examinations. Depending on their location and status, many other migrants may have never been screened for common illnesses, such as diabetes and hypertension. This is particularly true for vulnerable and disadvantaged migrant groups, such as refugees, asylum seekers and migrants displaced by conflict.

Healthcare disparities affecting access due to language and culture can occur, but also in some health jurisdictions in the USA there are legislative initiatives that may create barriers to available healthcare services on 'right of access' based on citizenship or 'willingness to pay' (self-pay or Medicare entitlement) issues. Migrants\' use of unregulated medical service providers may be an important component in the subsequent health assessment of this population. Migrant populations may also be using traditional, herbal, alternative or complementary medicines, some of which will be imported from abroad. Unregulated therapies and agents which do not meet standards of pharmacologic care in USA may not be revealed to attending healthcare professionals unless diligently sought. These alternate therapies may have the potential to complicate clinical presentations, and in some cases may themselves be a source of illness.

Many migrants from diverse backgrounds also have significant disparities in health determinants (e.g., socioeconomics, behavior, genetics and biology, environment) directly related to the migration process. The pre-departure component of health determination is carried through the migration process and is affected by the transit conditions; particularly for irregular arrivals, post-arrival period, and any return travel undertaken by the migrant or their offspring.

For the healthcare professional providing services to migrants, this requires an in-depth knowledge of the geographic components of health determination and disease expression that will be carried over to low prevalence or non-endemic countries, such as the USA. The historical focus of immigration and international public health has tended to be directed on contagious diseases of epidemic potential such as trachoma, syphilis, tuberculosis, and recently, HIV/AIDS. However, there has been a recent shift in attention to the personal health risks associated with immigration and other infectious and non-infectious diseases.

Summary {#s0040}
-------

[Table 18.2](#t0020){ref-type="table"} presents some of the clinical screening issues for healthcare providers working with defined migrant populations. With globalization of economies and trade, rapidity of inter-regional transportation, and increasing international population mobility for temporary and permanent relocation, healthcare professionals will be challenged to recognize both imported clinical syndromes and to be sensitive to quiescent conditions of both personal and public health significance when dealing with migrants. Mobile populations crossing boundaries of disease prevalence and with wide diversity represented in health determinant factors, will heighten disparities in disease risk in non-endemic or low-prevalence regions.TABLE 18.2Examples of medical screening of migrants by region, population, condition and interventionRegionPopulationInfectious disease conditionsNon-infectious conditionsInterventionLatin- AmericaMigrant workers -- agriculturalSTD, tuberculosis, intestinal parasitesSubstance use/abuse: alcohol, tobacco, othersAssessment and counseling; safer sex practices; HBV serology (HBsAg) and immunization of at-risk individuals. Tuberculin skin testing (TST) for children.Immunization -- routine, Hepatitis B; perinatal care and screening for maternal--child health (all at-risk populations); preventative Rx for existing conditions (e.g., syphilis, HIV, hypothyroidism, diabetes, hypertension)Migrant workers -- domesticTuberculosis, intestinal tapeworm (*T. solium* and other parasites) Hansen\'s diseaseDiet: caloric balance, micro-nutrient deficiencies, occupational risks -- physical violence, psychological abuse, toxin or dangerous environmental exposuresChildren of migrant laborersTuberculosisPhysical and mental developmental milestones, educational participation and attainmentEuropeWomen smuggled or trafficked; particularly from Eastern Europe (also Asia and Africa)Acquired risk environments and behaviors for STDsOccupational risks -- forced labor and commercial sex workers, physical and psychological abuse, violence, substance abuseAssessment and referral to justice and immigration protection servicesLocal standards of clinical practice and heighten suspicion of imported conditions of current low prevalence in USA and EuropeThe elderlyTuberculosis, tertiary syphilis; *Strongyloides* (southern Europe)The common diseases of advancing age: renal failure, malignancies, diabetes, hypertensionOther workersPrevious occupational exposures: asbestos, radiation, traumaAsiaMigrants from rural environmentsIntestinal parasites, including *Strongyloides*; tuberculosis, Hansen\'s disease; chronic HBV carriage (most populations of Asia, sub-Saharan Africa, parts of Oceania)*Note*: Pulmonary paragonimiasis can mimic TB. Liver flukes can lead to chronic hepatic scarringDietary deficiencies, acculturalization effects on mental statusOccupational and environmental health risksStools for parasites; serology for *Strongyloides*, HBV (HBsAg) and immunization of at-risk individuals. TST (children)Clinical assessment for cultural norms -- body mass, hematological and biochemical parametersAfricaRefugees*Note*: immigration medical waivers may have been given for screened Class A conditions (e.g., tuberculosis, STDs including HIV)Victims of: forced relocation, torture, rape, physical and psychological traumaPost-traumatic stress disordersNutritional deficiencies, particular in children and women of childbearing potentialNegative effects of acculturalizationIntestinal, blood and tissue parasites including *Strongyloides* (serology), schistosomiasis (urine), malaria. TST (children)Iron statusHBV serology (HBsAg) and immunization of at-risk individualsOceaniaHepatitis B, tuberculosis, Hansen\'s diseaseSerological screening: HBV (HBsAg) and immunization of at-risk individualsSkin examination. Heightened clinical suspicionNorth AmericaLong-term expatriates (humanitarian/relief workers, business travelers, 'overlanders' or backpackers)Sex touristsVisiting family and relatives -- migrant return travel; with or without local-born children or next generation travelCommunicable diseases endemic in the population and area of work or travelConsider exposures in VFRs (those who visit friends and families), immune status, local access and use of healthcare servicesCulture shock and other psychological adaptation disorders; acquired behavioral risksCultural components of foreign exposures; VFR: female circumcision; scarification, tattooing or piercingClinical assessment and management of post-exposure risks based on geographic environment and activities: tuberculosis, intestinal parasites, serology for strongyloides. TST for long-term exposure in high-prevalence countries*Note*: eosinophilia correlates poorly to the presence or absence of invasive helminthic infections

While screening can be targeted at asymptomatic individuals or for mass community screening activities for previously-defined at-risk populations, both of these are based on demographic and biometric profiles representing disparity in frequency or severity of outcome. Increasingly in high-health service regions with low prevalence of any poor health indicators, and excellent local public health programs, migrants and other mobile populations are becoming the 'at-risk' populations. Many of the factors impacting on adverse health outcomes in migrants are amenable to screening, and have effective interventions for health promotion or disease prevention.

High-risk populations of migrants, including refugees, workers, adopted children, victims of torture, and trafficked individuals may require specialized medical care as well as specifically designed screening based on medical and sociological assessment of their needs. Professional healthcare providers, health educational, training and professional societies, and governments and non-governmental agencies will be challenged to develop policies and programs to respond to this emerging and dynamic challenge to address the health needs of internationally mobile populations.
